The stock price of Nuwellis Inc (NASDAQ: NUWE) has jumped by 11.52 compared to previous close of 1.09. Despite this, the company has seen a gain of 18.63% in its stock price over the last five trading days. globenewswire.com reported 2024-12-19 that MINNEAPOLIS, Dec. 19, 2024 (GLOBE NEWSWIRE) — Nuwellis, Inc. (Nasdaq: NUWE) (the “Company” or “Nuwellis”) today announced that the Company received formal written notice from The Nasdaq Stock Market LLC (“Nasdaq”) that the Company has regained compliance with Nasdaq’s minimum bid price requirement (the “Bid Price Requirement”) set forth in Nasdaq Listing Rule 5550(a)(2), as well as Nasdaq’s stockholders’ equity requirement (“Equity Requirement”) set forth in Nasdaq Listing Rule 5550(b)(1). The Company’s Common Stock will continue to trade on The Nasdaq Capital Market tier of Nasdaq under the symbol “NUWE”.
Is It Worth Investing in Nuwellis Inc (NASDAQ: NUWE) Right Now?
The 36-month beta value for NUWE is at 0.29. Analysts have varying views on the stock, with 0 analysts rating it as a “buy,” 1 rating it as “overweight,” 1 as “hold,” and 0 as “sell.”
The public float for NUWE is 1.12M, and currently, shorts hold a 30.16% of that float. The average trading volume for NUWE on January 20, 2025 was 2.62M shares.
NUWE’s Market Performance
NUWE stock saw an increase of 18.63% in the past week, with a monthly gain of 1.68% and a quarterly increase of -13.57%. The volatility ratio for the week is 7.31%, and the volatility levels for the last 30 days are 8.57% for Nuwellis Inc (NUWE). The simple moving average for the past 20 days is 10.73% for NUWE’s stock, with a -69.52% simple moving average for the past 200 days.
Analysts’ Opinion of NUWE
Many brokerage firms have already submitted their reports for NUWE stocks, with ROTH MKM repeating the rating for NUWE by listing it as a “Buy.” The predicted price for NUWE in the upcoming period, according to ROTH MKM is $17 based on the research report published on July 29, 2024 of the previous year 2024.
NUWE Trading at -7.00% from the 50-Day Moving Average
After a stumble in the market that brought NUWE to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -95.62% of loss for the given period.
Volatility was left at 8.57%, however, over the last 30 days, the volatility rate increased by 7.31%, as shares surge +23.79% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -56.94% lower at present.
During the last 5 trading sessions, NUWE rose by +18.63%, which changed the moving average for the period of 200-days by -90.93% in comparison to the 20-day moving average, which settled at $1.0927. In addition, Nuwellis Inc saw 9.01% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for NUWE
Current profitability levels for the company are sitting at:
- -1.36 for the present operating margin
- 0.64 for the gross margin
The net margin for Nuwellis Inc stands at -1.64. The total capital return value is set at -3.03. Equity return is now at value -276.02, with -167.47 for asset returns.
Based on Nuwellis Inc (NUWE), the company’s capital structure generated 0.16 points at debt to capital in total, while cash flow to debt ratio is standing at -18.07. The debt to equity ratio resting at 0.19. The interest coverage ratio of the stock is -1.34.
Currently, EBITDA for the company is -16.36 million with net debt to EBITDA at 0.13. When we switch over and look at the enterprise to sales, we see a ratio of 0.44. The receivables turnover for the company is 6.94for trailing twelve months and the total asset turnover is 1.33. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.03.
Conclusion
In conclusion, Nuwellis Inc (NUWE) has had a mixed performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.